The text starts here.

Access to Medicines

Our Approach


May 7, 2012

3. Eisai Advocacy work examples (1/3)

  1. 1)Industry Associations
    As a global company, Eisai is a member of a large number of the associations around the world that represent the R&D-based pharmaceutical industry. Associations of which Eisai is a member are presented as follows. Eisai is happy to confirm whether or not it is a member of any other industry association, upon request.
  1. ・International Federation of Pharmaceutical Manufacturers and Associations (IFPMA),
  2. ・Japan Pharmaceutical Manufacturers Association (JPMA),
  3. ・Pharmaceutical Research and Manufacturers of America (PhRMA),
  4. ・European Federation of Pharmaceutical Industries and Associations (EFPIA),
  5. ・R&D-based Pharmaceutical Association Committee (RDPAC) of China,
  6. ・Organisation of Pharmaceutical Producers of India (OPPI),
  7. ・Association of International Pharmaceutical Manufacturers (AIPM) of Russia,

2012 Asia Partnership Conference of Pharmaceutical Industries (APCPA)

The first pharmaceutical industry Asia Partnership Conference was held in Tokyo in March 2012. This event brought together representatives of pharmaceutical industry associations with IFPMA membership from twelve associations of the region, under the theme of “Rapid and reliable delivery of medicines to the peoples of Asia”. Eisai was proud to be working with the JPMA and the other Asian industry associations to help improve patient access to innovative medicines.

Related Links